Human acute myelogenous leukemia stem cells revisited: there's more than meets the eye.
In this issue of Cancer Cell, Goardon et al. revise earlier conclusions regarding acute myelogenous leukemia (AML) stem cells by demonstrating that in the majority of patients, they reside in two hierarchically related populations most similar to normal hematopoietic progenitors. These findings have implications for therapeutic targeting of these cells.
Department of Internal Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA 94305, USA. rmajeti@stanford.edu
Ravindra
R
Majeti
Irving L
IL
Weissman
JAMA. 2010 Dec 22;304(24):2706-15
21177505
Blood. 2008 Aug 1;112(3):568-75
18523148
JAMA. 2005 Sep 21;294(11):1359-66
16174694
Blood. 2010 Mar 11;115(10):1976-84
20053758
Nat Med. 1997 Jul;3(7):730-7
9212098
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7521-6
10861016
N Engl J Med. 2004 Aug 12;351(7):657-67
15306667
Nature. 2006 Aug 17;442(7104):818-22
16862118
Cancer Cell. 2011 Jan 18;19(1):138-52
21251617
Cell Stem Cell. 2007 Dec 13;1(6):635-45
18371405
Cell. 2009 Jul 23;138(2):286-99
19632179